BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

110 related articles for article (PubMed ID: 36098711)

  • 21. Tanshinone I restrains osteosarcoma progression by regulating circ_0000376/miR-432-5p/BCL2 axis.
    Ye B; Qiao K; Zhao Q; Jiang Z; Hu N; Wang F
    Mol Cell Biochem; 2022 Jan; 477(1):1-13. PubMed ID: 34532813
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Prognostic value of microRNA-223/epithelial cell transforming sequence 2 signaling in patients with osteosarcoma.
    Zhang H; Yin Z; Ning K; Wang L; Guo R; Ji Z
    Hum Pathol; 2014 Jul; 45(7):1430-6. PubMed ID: 24784921
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Effect of miR-143 on the apoptosis of osteosarcoma cells.
    Liu H; Wang H; Liu H; Chen Y
    Int J Clin Exp Pathol; 2015; 8(11):14241-6. PubMed ID: 26823739
    [TBL] [Abstract][Full Text] [Related]  

  • 24. MiR-451 inhibits cell growth and invasion by targeting CXCL16 and is associated with prognosis of osteosarcoma patients.
    Zhang F; Huang W; Sheng M; Liu T
    Tumour Biol; 2015 Mar; 36(3):2041-8. PubMed ID: 25391425
    [TBL] [Abstract][Full Text] [Related]  

  • 25. MicroRNA-645 promotes metastasis of osteosarcoma via targeting tumor suppressor NM23 nucleoside diphosphate kinase 2.
    Jiao GJ; Zhang SJ; Li Y; Wu WL; Liu HC
    Clin Exp Pharmacol Physiol; 2018 Dec; 45(12):1317-1324. PubMed ID: 29956840
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Circular RNA hsa_circ_0000282 contributes to osteosarcoma cell proliferation by regulating miR-192/XIAP axis.
    Li H; He L; Tuo Y; Huang Y; Qian B
    BMC Cancer; 2020 Oct; 20(1):1026. PubMed ID: 33097010
    [TBL] [Abstract][Full Text] [Related]  

  • 27. MiR-454 prompts cell proliferation of human colorectal cancer cells by repressing CYLD expression.
    Liang HL; Hu AP; Li SL; Xie JP; Ma QZ; Liu JY
    Asian Pac J Cancer Prev; 2015; 16(6):2397-402. PubMed ID: 25824771
    [TBL] [Abstract][Full Text] [Related]  

  • 28. miR-182 controls cell growth in gastrointestinal stromal tumors by negatively regulating CYLD expression.
    Ling T; Yu F; Cao H
    Oncol Rep; 2018 Dec; 40(6):3705-3713. PubMed ID: 30542706
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Triptolide inhibits the growth of osteosarcoma by regulating microRNA-181a via targeting PTEN gene in vivo and vitro.
    Jiang C; Fang X; Zhang H; Wang X; Li M; Jiang W; Tian F; Zhu L; Bian Z
    Tumour Biol; 2017 Apr; 39(4):1010428317697556. PubMed ID: 28381158
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Decreased microRNA-452 expression and its prognostic significance in human osteosarcoma.
    Li RZ; Wang LM
    World J Surg Oncol; 2016 May; 14():150. PubMed ID: 27193084
    [TBL] [Abstract][Full Text] [Related]  

  • 31. MicroRNA-301b promotes cell proliferation and apoptosis resistance in triple-negative breast cancer by targeting CYLD.
    Song H; Li D; Wu T; Xie D; Hua K; Hu J; Deng X; Ji C; Deng Y; Fang L
    BMB Rep; 2018 Nov; 51(11):602-607. PubMed ID: 30269739
    [TBL] [Abstract][Full Text] [Related]  

  • 32. miRNA-646 suppresses osteosarcoma cell metastasis by downregulating fibroblast growth factor 2 (FGF2).
    Sun XH; Geng XL; Zhang J; Zhang C
    Tumour Biol; 2015 Mar; 36(3):2127-34. PubMed ID: 25403884
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Overexpression of microRNA-495 suppresses the proliferation and invasion and induces the apoptosis of osteosarcoma cells by targeting high-mobility group nucleosome-binding domain 5.
    Jiang W; Zheng J; Yu T; Wang J
    Oncol Rep; 2017 Aug; 38(2):1099-1107. PubMed ID: 28627703
    [TBL] [Abstract][Full Text] [Related]  

  • 34. MiR-155 affects osteosarcoma cell proliferation and invasion through regulating NF-κB signaling pathway.
    Lu S; Liao QS; Tang L
    Eur Rev Med Pharmacol Sci; 2018 Nov; 22(22):7633-7639. PubMed ID: 30536304
    [TBL] [Abstract][Full Text] [Related]  

  • 35. MicroRNA-34a inhibits human osteosarcoma proliferation by downregulating ether à go-go 1 expression.
    Wu X; Zhong D; Gao Q; Zhai W; Ding Z; Wu J
    Int J Med Sci; 2013; 10(6):676-82. PubMed ID: 23569431
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Serum microRNA-221 functions as a potential diagnostic and prognostic marker for patients with osteosarcoma.
    Yang Z; Zhang Y; Zhang X; Zhang M; Liu H; Zhang S; Qi B; Sun X
    Biomed Pharmacother; 2015 Oct; 75():153-8. PubMed ID: 26422796
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Upregulated expression of microRNA-214 is linked to tumor progression and adverse prognosis in pediatric osteosarcoma.
    Wang Z; Cai H; Lin L; Tang M; Cai H
    Pediatr Blood Cancer; 2014 Feb; 61(2):206-10. PubMed ID: 24038809
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Expression of microRNA-150 and its Target Gene IGF2BP1 in Human Osteosarcoma and their Clinical Implications.
    Wang L; Aireti A; Aihaiti A; Li K
    Pathol Oncol Res; 2019 Apr; 25(2):527-533. PubMed ID: 30220021
    [TBL] [Abstract][Full Text] [Related]  

  • 39. MiR-384 Inhibits Malignant Biological Behavior Such as Proliferation and Invasion of Osteosarcoma by Regulating IGFBP3.
    Tan Y; Chen L; Li S; Hao H; Zhang D
    Technol Cancer Res Treat; 2020; 19():1533033820909125. PubMed ID: 32129151
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Tumor suppressing role of serum-derived exosomal microRNA-15a in osteosarcoma cells through the GATA binding protein 2/murine double minute 2 axis and the p53 signaling pathway.
    Wu C; Li Z; Feng G; Wang L; Xie J; Jin Y; Wang L; Liu S
    Bioengineered; 2021 Dec; 12(1):8378-8395. PubMed ID: 34592889
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.